D56 Thalassemia Notes: Alpha thalassemia major ; Hemoglobin H Constant Spring ; Hemoglobin H disease ; Hydrops fetalis due t…

Thalassemia
Notes: Alpha thalassemia major ; Hemoglobin H Constant Spring ; Hemoglobin H disease ; Hydrops fetalis due to alpha thalassemia ; Severe alpha thalassemia ; Triple gene defect alpha thalassemia ; Beta thalassemia major ; Cooley’s anemia ; Homozygous beta thalassemia ; Severe beta thalassemia ; Thalassemia intermedia ; Thalassemia major ; Homozygous delta-beta thalassemia ; Alpha thalassemia minor ; Alpha thalassemia silent carrier ; Alpha thalassemia trait ; Beta thalassemia minor ; Beta thalassemia trait ; Delta-beta thalassemia minor ; Delta-beta thalassemia trait ; Thalassemia trait NOS ; Dominant thalassemia ; Hemoglobin C thalassemia ; Mixed thalassemia ; Thalassemia with other hemoglobinopathy ; Mediterranean anemia (with other hemoglobinopathy) ; code, if applicable, for hydrops fetalis due to alpha thalassemia (P56.99) ; sickle-cell thalassemia (D57.4-) ; alpha thalassemia trait or minor (D56.3) ; asymptomatic alpha thalassemia (D56.3) ; hydrops fetalis due to isoimmunization (P56.0) ; hydrops fetalis not due to immune hemolysis (P83.2) ; beta thalassemia minor (D56.3) ; beta thalassemia trait (D56.3) ; delta-beta thalassemia (D56.2) ; hemoglobin E-beta thalassemia (D56.5) ; sickle-cell beta thalassemia (D57.4-) ; delta-beta thalassemia minor (D56.3) ; delta-beta thalassemia trait (D56.3) ; alpha thalassemia (D56.0) ; beta thalassemia (D56.1) ; delta-beta thalassemia (D56.2) ; hemoglobin E-beta thalassemia (D56.5) ; sickle-cell trait (D57.3) ; beta thalassemia (D56.1) ; beta thalassemia minor (D56.3) ; beta thalassemia trait (D56.3) ; delta-beta thalassemia (D56.2) ; delta-beta thalassemia trait (D56.3) ; hemoglobin E disease (D58.2) ; other hemoglobinopathies (D58.2) ; sickle-cell beta thalassemia (D57.4-) ; hemoglobin C disease (D58.2) ; hemoglobin E disease (D58.2) ; other hemoglobinopathies (D58.2) ; sickle-cell anemia (D57.-) ; sickle-cell thalassemia (D57.4)

Share

Comments are closed.